SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19

NCT06050460 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: SA55 Injection
OTHER: Placebo for SA55 injection

Sponsor

Sinovac Life Sciences Co., Ltd.